Story perspectives

FDA Reviews Controversial Food Additive BHA for Safety

2/10/2026

Summary

Story summary

The U.S. Food and Drug Administration will review butylated hydroxyanisole (BHA) as part of a broader reassessment of food additives.
Health and Human Services Secretary Robert F. Kennedy Jr. urged rigorous safety standards after the National Toxicology Program classified BHA as "reasonably anticipated to be a human carcinogen."
The FDA will evaluate other chemicals, including butylated hydroxytoluene (BHT) and azodicarbonamide (ADA).
The agency aims to enhance transparency and oversight of food additives.

1 of 1

Story summary

The U.S. Food and Drug Administration will review butylated hydroxyanisole (BHA) as part of a broader reassessment of food additives.
Health and Human Services Secretary Robert F. Kennedy Jr. urged rigorous safety standards after the National Toxicology Program classified BHA as "reasonably anticipated to be a human carcinogen."
The FDA will evaluate other chemicals, including butylated hydroxytoluene (BHT) and azodicarbonamide (ADA).
The agency aims to enhance transparency and oversight of food additives.